Creative Biolabs Presented Its Expertise at the 87th Cold Spring Harbor Laboratory Symposium
New York, USA – June 15, 2023 – The Cold Spring Harbor Symposium is a series of annual scientific conferences organized by the Cold Spring Harbor Laboratory, which covers extensive topics in biology and attracts organizers, instructors, and participants across the world. Creative Biolabs is one of the sponsors of the 87th Symposium heading Stem Cells, showcasing its solutions around stem cell research through the vendor exhibition hours from May 31 to June 4.
“We’re excited to meet so many industry and academic scientists here,” said one of the scientists onsite, “thanks to this great event held by CSHL. The topic is perfectly in line with our scope of capabilities, providing a great opportunity for us to present our stem cell solutions.”
Creative Biolabs provides stem cell research services for cancer therapy. They offer a range of services, including the production of stem cells for cancer treatment, induced pluripotent stem cell (iPSC) differentiation, mesenchymal stem cell (MSC) isolation and expansion, genome editing services for stem cells using CRISPR/Cas9 technology, and lentiviral vector design for stem cell research.
“Current research trends reveal the significance of iPSC as tools for therapeutics,” said the scientist, “and bearing that in mind, we’ve developed a set of services to back the research on iPSC therapy.”
Currently, Creative Biolabs supports iPSC therapy discovery mainly through two streams-iPSC derived stem cell therapy and iPSC derived immune cell therapy.
“Technically speaking, the basis of the services is all around stem cell differentiation,” introduced the scientist, “by which we’re able to differentiate iPSC into macrophages for immunotherapy and produce tumor specific NK cells and T lymphocytes for cell therapy.”
In addition, the company also outlined its genome editing solutions for stem cells, which are based on transcription activator-like effectors (TALEs), clustered regularly interspaced short palindromic repeats (CRISPR), and recombinant technology.
“We feel really thankful about this event hosted by CSHL,” concluded the scientist, “where we got to know many new friends. In 2023, there will be many chances to see us on such occasions. Looking forward to getting to know more friends that are in the same area with us.”
Learn more about Creative Biolabs services and event arrangements at https://www.creative-biolabs.com.
About
Creative Biolabs is a CRO providing services to support biomedical research, whose capabilities range from the discovery of antibody-based therapies, cell therapy, gene therapy, all the way to therapy validation. A group of scientists will participate in global networking affairs concentrating on biotechnology innovation, research progress, and drug discovery in 2023.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
